Stock Comparison
ABBV vs AMGN
AbbVie Inc and Amgen Inc side by side — valuation, profitability, growth and risk.
Valuation
Market Cap
$447.62B
$193.39B
P/E (TTM)
123.6
24.9
Forward P/E
17.8
16.1
Price/Sales
7.1
5.2
Price/Book
50.5
21.0
EV/EBITDA
30.2
14.3
Dividend Yield
2.77%
2.74%
Profitability
Net Margin
5.79%
21.00%
Operating Margin
32.20%
33.80%
Return on Equity
62.30%
101.30%
Return on Assets
10.00%
8.35%
Growth (YoY)
Revenue Growth
12.40%
5.80%
Earnings Growth
-46.20%
4.40%
Price & Risk
Beta
0.3
0.4
52-Week High
$253.35
$388.36
52-Week Low
$176.02
$264.02
Analyst Target
$254.38
$352.77
Compare ABBV and AMGN your own way
Try mrmarket.ai freeFigures are sourced from company filings and market data and may be delayed or revised. For informational purposes only — not investment advice.